XBiotech
Quarterly Financials
| Values in thousands | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -332 | -378 | -427 | -439 |
EBITDA | -5,124 | -26,438 | -5,479 | -1,289 |
EBIT | -5,456 | -26,816 | -5,906 | -1,728 |
Net Income | -5,505 | -26,892 | -6,008 | -1,756 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -8,969 | -22,986 | -4,369 | -6,040 |
Cash | 115,459 | 125,551 | 147,367 | 152,938 |
Basic Shares | 30,487 | 30,487 | 30,487 | 30,487 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $300 | $4,010 |
Gross Profit | -1,686 | -1,744 | 3,359 | |
EBITDA | -43,531 | -36,011 | -22,569 | -30,974 |
EBIT | -45,217 | -37,756 | -24,313 | -33,588 |
Net Income | -45,540 | -38,531 | -24,557 | -32,900 |
Net Change In Cash | 0 | 0 | 300 | 4,010 |
Cost of Revenue | -78,716 | |||
Free Cash Flow | -40,209 | -32,267 | -19,087 | -15,409 |
Cash | 125,551 | 172,677 | 200,023 | 157,306 |
Basic Shares | 30,487 | 30,460 | 30,438 | 30,439 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | -$0.18 |
2025-12-31 | -$0.88 |
2025-09-30 | -$0.20 |
2025-06-30 | -$0.06 |